Latest Articles

The identification of this target is particularly exciting as it is unique to tumour cells, meaning that it is less toxic compared to existing therapies.

This article will describe the workflow, methods and equipment used for freezing, storage and thawing samples.

CRISPRa is a widely applicable tool for untying genetic interactions in all kinds of cells and could be used to build functional regulatory maps of the human genome.

No longer confined to research projects and blue sky thinking, personalised medicine is having an impact in the real world, providing smarter diagnosis, guiding treatment decisions and producing better outcomes.

In this article, we chat to James Mcllory, CEO of EnteroBiotix, a Scottish biotech working to modulate the human microbiome to address unmet clinical needs.

To better understand the key challenges and pain points in the global laboratory market, Agilent commissioned Frost & Sullivan to carry out an independent survey of 700 scientists across the laboratory employee spectrum. Here we highlight a selection of the survey’s key findings.

The complexities of tumor genomes are rapidly being uncovered, but how they are regulated into functional proteomes remains poorly understood, until now.

Researchers recently evaluated whether a blood-based biomarker detected by ddPCR could indicate how well patients with non-small cell lung cancer (NSCLC) respond to immunotherapies.

The advent of gene editing techniques has generated more excitement in biology and medicine than any discovery since polymerase chain reaction thirty years ago. By allowing the removal or addition of nearly any gene into any cell, gene editing circumvents tedious, lengthy development of cell lines for research and biomanufacturing.

Epigenetic phenomena such as paramutation, transgenic silencing, imprinting, and transposable element inactivation are prevalent in plants and potentially offer a huge resource for directed crop improvement.